{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:17:12Z","timestamp":1790234232604,"version":"4.1.0"},"reference-count":160,"publisher":"Elsevier","isbn-type":[{"value":"9780128120736","type":"print"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1016\/bs.acc.2017.06.005","type":"book-chapter","created":{"date-parts":[[2017,8,7]],"date-time":"2017-08-07T03:17:01Z","timestamp":1502075821000},"page":"1-46","source":"Crossref","is-referenced-by-count":134,"title":["Calcium and Bone Metabolism Indices"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.acc.2017.06.005_bb0010","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.2215\/CJN.04151206","article-title":"Normal bone anatomy and physiology","volume":"3","author":"Clark","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/bs.acc.2017.06.005_bb0015","series-title":"Henry's Clinical Diagnosis and Management by Laboratory Methods","first-page":"193","article-title":"Biochemical markers of bone metabolism","author":"Klemm","year":"2011"},{"key":"10.1016\/bs.acc.2017.06.005_bb0020","first-page":"119","article-title":"Renal and intestinal calcium transport: roles of vitamin D and vitamin D-dependent calcium binding proteins","volume":"14","author":"Johnson","year":"1994","journal-title":"Semin. Nephrol."},{"key":"10.1016\/bs.acc.2017.06.005_bb0025","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/ajcn\/86.4.1054","article-title":"Calcium requirements: new estimations for men and women by cross-sectional statistical analyses of calcium balance data from metabolic studies","volume":"86","author":"Hunt","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/bs.acc.2017.06.005_bb0030","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2215\/CJN.09750913","article-title":"Renal control of calcium, phosphate, and magnesium homeostasis","volume":"10","author":"Blaine","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/bs.acc.2017.06.005_bb0035","series-title":"UpToDate","article-title":"Parathyroid hormone secretion and action","author":"El-Hajj Fuleihan","year":"2014"},{"key":"10.1016\/bs.acc.2017.06.005_bb0040","series-title":"Contemporary Practice in Clinical Chemistry","first-page":"506","article-title":"Calcium biology and disorders","author":"Winter","year":"2011"},{"key":"10.1016\/bs.acc.2017.06.005_bb0045","series-title":"Dynamics of Bone and Cartilage Metabolism","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/B9-78-012088-5\/62650-0170","article-title":"Parathyroid hormone: structure, function, and dynamic actions","author":"Fitzpatrick","year":"2006"},{"key":"10.1016\/bs.acc.2017.06.005_bb0050","doi-asserted-by":"crossref","unstructured":"A. B. Hodsman, D. C. Bauer, D. W. Dempster, L. Dian, D. A. Hanly, S. T. Harris, et al., Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use, Endocr. Rev., 26 (2005), pp. 688\u2013703.","DOI":"10.1210\/er.2004-0006"},{"key":"10.1016\/bs.acc.2017.06.005_bb0055","series-title":"Tietz Textbook of Clinical Chemistry and Molecular Diagnostics","first-page":"1757","article-title":"Bone and mineral metabolism","author":"Risteli","year":"2012"},{"key":"10.1016\/bs.acc.2017.06.005_bb0060","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1590\/S0004-27302006000400008","article-title":"The calcium-sensing receptor and related diseases","volume":"50","author":"D\u2019Souza-Li","year":"2006","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"issue":"3","key":"10.1016\/bs.acc.2017.06.005_bb0065","doi-asserted-by":"crossref","first-page":"F485","DOI":"10.1152\/ajprenal.00608.2009","article-title":"Physiology and pathophysiology of the calcium-sensing receptor in the kidney","volume":"298","author":"Ricardi","year":"2010","journal-title":"Am. J. Phyiol. Renal Physiol."},{"key":"10.1016\/bs.acc.2017.06.005_bb0070","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1073\/pnas.82.12.4270","article-title":"Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells","volume":"82","author":"Silver","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.acc.2017.06.005_bb0075","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1210\/endo-119-6-2864","article-title":"Suppression by 1,25(OH)2 D3 of transcription of the pre-proparathyroid hormone gene","volume":"119","author":"Russell","year":"1986","journal-title":"Endocrinology"},{"key":"10.1016\/bs.acc.2017.06.005_bb0080","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1172\/JCI112714","article-title":"Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat","volume":"78","author":"Silver","year":"1986","journal-title":"J. Clin. Invest."},{"key":"10.1016\/bs.acc.2017.06.005_bb0085","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1681\/ASN.V9101845","article-title":"High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro","volume":"9","author":"Almaden","year":"1998","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/bs.acc.2017.06.005_bb0090","first-page":"37","article-title":"Mechanisms of hypocalcemia in the clinical form of severe magnesium deficit in the human","volume":"5","author":"Leicht","year":"1992","journal-title":"Magnes. Res."},{"key":"10.1016\/bs.acc.2017.06.005_bb0095","series-title":"Primer on the Metabolic Bone Disease and Disorders of Mineral Metabolism","first-page":"104","article-title":"Regulation of calcium and magnesium","author":"Favus","year":"2008"},{"key":"10.1016\/bs.acc.2017.06.005_bb0100","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1210\/jc.2005-1628","article-title":"Acute regulation of circulating parathyroid hormone(PTH) molecular forms by calcium: utility of PTH fragments\/PTH(1-84) ratios derived from three generations of PTH assays","volume":"91","author":"D\u2019Amour","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2017.06.005_bb0105","series-title":"Principles of Bone Biology","first-page":"325","article-title":"Parathyroid hormone: molecular biology regulation","author":"Potts","year":"1996"},{"key":"10.1016\/bs.acc.2017.06.005_bb0110","first-page":"249","article-title":"Biosynthesis of parathyroid hormone","volume":"33","author":"Habener","year":"1976","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/bs.acc.2017.06.005_bb0115","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1210\/er.2003-0024","article-title":"Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal region and related biological actions of carboxyl-terminal ligands","volume":"26","author":"Murray","year":"2005","journal-title":"Endocr. Rev."},{"key":"10.1016\/bs.acc.2017.06.005_bb0120","series-title":"Handbook of Physiology, Section 7: The Endocrine System","article-title":"Regulation of parathyroid function","author":"Diaz","year":"1999"},{"key":"10.1016\/bs.acc.2017.06.005_bb0125","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1373\/clinchem.2003.026328","article-title":"Potential clinical utility of a new IRMA for parathyroid hormone in postmenopausal patients with primary hyperparathyroidism","volume":"50","author":"Carnevale","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2017.06.005_bb0130","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/endo.143.1.8575","article-title":"Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH\/PTHrP receptor","volume":"143","author":"Divieti","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/bs.acc.2017.06.005_bb0135","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1590\/S0004-27302006000400007","article-title":"Evolution of PTH assays","volume":"50","author":"Vieira","year":"2006","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"10.1016\/bs.acc.2017.06.005_bb0140","first-page":"3923","article-title":"Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values","volume":"81","author":"Brossard","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2017.06.005_bb0145","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1210\/jcem.84.11.6236","article-title":"A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure","volume":"84","author":"John","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2017.06.005_bb0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ki.2009.374","article-title":"Parathyroid hormone measurement in CKD","volume":"77","author":"Souberbielle","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/bs.acc.2017.06.005_bb0155","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1053\/j.ajkd.2010.02.340","article-title":"KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the diagnosis, evaluation, and treatment of CKD-mineral and bone disorder (CKD-MBD)","volume":"55","author":"Uhlig","year":"2010","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/bs.acc.2017.06.005_bb0160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1373\/clinchem.2009.137323","article-title":"Selected reaction monitoring-mass spectrometric immunoassay responsive to parathyroid hormone and related variants","volume":"56","author":"Lopez","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2017.06.005_bb0165","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1373\/clinchem.2009.134643","article-title":"Quantification of serum 1-84 parathyroid hormone in patients with hyperparathyroidism by immunocapture in situ digestion liquid chromatography-tandem mass spectrometry","volume":"56","author":"Kumar","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2017.06.005_bb0170","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1515\/cclm-2014-0150","article-title":"LC-MS candidate reference methods for the harmonisation of parathyroid hormone (PTH) measurement: a review of recent developments and future considerations","volume":"52","author":"Couchman","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/bs.acc.2017.06.005_bb0175","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0002-9610(91)90135-Z","article-title":"Operative monitoring of parathyroid gland hyperfunction","volume":"162","author":"Irvin","year":"1991","journal-title":"Am. J. Surg."},{"key":"10.1016\/bs.acc.2017.06.005_bb0180","first-page":"2090","article-title":"Excision under local anesthesia of parathyroid adenomas. Criteria of selection and control of effectiveness. 35 cases","volume":"20","author":"Chapuis","year":"1991","journal-title":"Presse Med."},{"key":"10.1016\/bs.acc.2017.06.005_bb0185","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.surg.2012.08.022","article-title":"Is minimally invasive parathyroidectomy associated with greater recurrence compared to bilateral exploration? Analysis of more than 1,000 cases","volume":"152","author":"Schneider","year":"2012","journal-title":"Surgery"},{"key":"10.1016\/bs.acc.2017.06.005_bb0190","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jamcollsurg.2009.05.029","article-title":"National trends in parathyroid surgery from 1998 to 2008: a decade of change","volume":"209","author":"Greene","year":"2009","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/bs.acc.2017.06.005_bb0195","series-title":"UpToDate","article-title":"Intraoperative parathyroid hormone assays","author":"Solorzano","year":"2015"},{"key":"10.1016\/bs.acc.2017.06.005_bb0200","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00268-013-2329-6","article-title":"The final intraoperative parathyroid hormone level: how low should it go?","volume":"38","author":"Wharry","year":"2014","journal-title":"World J. Surg."},{"key":"10.1016\/bs.acc.2017.06.005_bb0205","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1245\/s10434-014-4201-9","article-title":"What can we learn from intraoperative parathyroid hormone levels that do not drop appropriately?","volume":"22","author":"Wachtel","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/bs.acc.2017.06.005_bb0210","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0039-6060(97)90215-4","article-title":"Concise parathyroidectomy: the impact of preoperative SPECT 99mTc sestamibi scanning and intraoperative quick parathormone assay","volume":"122","author":"Carty","year":"1997","journal-title":"Surgery"},{"key":"10.1016\/bs.acc.2017.06.005_bb0215","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1067\/msy.2002.128479","article-title":"Elevated serum parathormone level after \u201cconcise parathyroidectomy\u201d for primary sporadic hyperparathyroidism","volume":"132","author":"Carty","year":"2002","journal-title":"Surgery"},{"key":"10.1016\/bs.acc.2017.06.005_bb0220","series-title":"Tietz Textbook of Clinical Chemistry and Molecular Diagnostics","first-page":"1765","article-title":"Bone and mineral metabolism","author":"Winter","year":"2012"},{"key":"10.1016\/bs.acc.2017.06.005_bb0225","series-title":"UpToDate","article-title":"Overview of vitamin D","author":"Pazirandeh","year":"2016"},{"key":"10.1016\/bs.acc.2017.06.005_bb0230","series-title":"UpToDate","article-title":"Vitamin D deficiency in adults: definition, clinical manifestations, and treatment","author":"Dawson-Hughes","year":"2016"},{"key":"10.1016\/bs.acc.2017.06.005_bb0235","doi-asserted-by":"crossref","unstructured":"B. Dawson-Hughes, S. S. Harris, E. A. Krall, G. E. Dallal, Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older, N. Engl. J. Med. 337 (1997), p.670.","DOI":"10.1056\/NEJM199709043371003"},{"key":"10.1016\/bs.acc.2017.06.005_bb0240","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s001980200023","article-title":"Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study","volume":"13","author":"Chapuy","year":"2002","journal-title":"Osteoporos. Int."},{"key":"10.1016\/bs.acc.2017.06.005_bb0245","doi-asserted-by":"crossref","unstructured":"D. P. Trivedi, R. Doll, K. T. Khaw, Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial, BMJ 326 (2003), p. 469.","DOI":"10.1136\/bmj.326.7387.469"},{"key":"10.1016\/bs.acc.2017.06.005_bb0250","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1001\/jama.2010.594","article-title":"Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial","volume":"303","author":"Sanders","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/bs.acc.2017.06.005_bb0255","series-title":"Food and Nutrition Board, Dietary Reference Intakes for Calcium and Vitamin D","author":"Institute of Medicine","year":"2010"},{"key":"10.1016\/bs.acc.2017.06.005_bb0260","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1373\/clinchem.2011.176545","article-title":"Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration","volume":"58","author":"Heijboer","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2017.06.005_bb0265","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1373\/clinchem.2011.172155","article-title":"State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography\u2013tandem mass spectrometry methods","volume":"58","author":"Farrell","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2017.06.005_bb0270","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1373\/clinchem.2005.052936","article-title":"Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3","volume":"51","author":"Maunsell","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2017.06.005_bb0275","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1210\/jc.2006-0710","article-title":"C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status","volume":"91","author":"Singh","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2017.06.005_bb0280","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.cca.2011.05.010","article-title":"Isotope dilution ultra performance liquid chromatography-tandem mass spectrometry method for simultaneous measurement of 25-hydroxyvitamin D2, 25-hydroxyvitamin D3 and 3-epi-25-hydroxyvitamin D3 in human serum","volume":"412","author":"Schleicher","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/bs.acc.2017.06.005_bb0285","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1210\/jc.2016-1104","article-title":"Free 25-hydroxyvitamin D: impact of vitamin D binding protein assays on racial-genotypic associations","volume":"101","author":"Nielson","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2017.06.005_bb0290","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa1306357","article-title":"Vitamin D-binding protein and vitamin D status of black Americans and white Americans","volume":"369","author":"Powe","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.acc.2017.06.005_bb0295","series-title":"Contemporary Practice in Clinical Chemistry","first-page":"510","article-title":"Calcium biology and disorders","author":"Winter","year":"2011"},{"key":"10.1016\/bs.acc.2017.06.005_bb0300","series-title":"William Textbook of Endocrinology","first-page":"1340","article-title":"Hormones and disorders of mineral metabolism","author":"Kronenberg","year":"2003"},{"key":"10.1016\/bs.acc.2017.06.005_bb0305","series-title":"Tietz Textbook of Clinical Chemistry and Molecular Diagnostics","first-page":"1738","article-title":"Bone and mineral metabolism","author":"Risteli","year":"2012"},{"key":"10.1016\/bs.acc.2017.06.005_bb0310","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1002\/jbmr.5650061422","article-title":"Asymptomatic primary hyperparathyroidism","volume":"6","author":"Mitlak","year":"1991","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/bs.acc.2017.06.005_bb0315","series-title":"Contemporary Practice in Clinical Chemistry","first-page":"515","article-title":"Calcium biology and disorders","author":"Winter","year":"2011"},{"key":"10.1016\/bs.acc.2017.06.005_bb0320","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/archinte.1990.00390190133021","article-title":"Long-term irreversibility of bone loss after surgery for primary hyperparathyroidism","volume":"150","author":"Martin","year":"1990","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/bs.acc.2017.06.005_bb0325","first-page":"723","article-title":"Longitudinal measurements of bone density and biochemical indices in untreated primary hyperparathyroidism","volume":"80","author":"Silverberg","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2017.06.005_bb0330","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","article-title":"Primary hyperparathyroidism and the risk of fracture","volume":"14","author":"Khosla","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/bs.acc.2017.06.005_bb0335","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMcp042806","article-title":"Clinical practice. Hypercalcemia associated with cancer","volume":"352","author":"Stewart","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.acc.2017.06.005_bb0340","series-title":"UpToDate","article-title":"Hypercalcemia of malignancy","author":"Horwitz","year":"2014"},{"key":"10.1016\/bs.acc.2017.06.005_bb0345","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1046\/j.1365-2796.2003.01168.x","article-title":"Hyperparathyroidism-jaw tumour syndrome","volume":"253","author":"Chen","year":"2003","journal-title":"J. Intern. Med."},{"key":"10.1016\/bs.acc.2017.06.005_bb0350","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s002230001201","article-title":"The prevalence of familial hypocalciuric hypercalcemia","volume":"68","author":"Hinnie","year":"2001","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/bs.acc.2017.06.005_bb0355","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/clinchem\/19.10.1208","article-title":"A referee method for the determination of total calcium in serum","volume":"19","author":"Cali","year":"1973","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2017.06.005_bb0360","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/clinchem\/36.2.351","article-title":"Method comparison for calcium determination by flame atomic absorption spectrophotometry in the presence of phosphate","volume":"36","author":"Welch","year":"1990","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2017.06.005_bb0365","unstructured":"CALCIUM oCPC [package insert], Brea, CA, Beckman Coulter Inc., 2009."},{"key":"10.1016\/bs.acc.2017.06.005_bb0370","unstructured":"CALCIUM (ARSENAZO) [package insert], Brea, CA, Beckman Coulter Inc., 2009."},{"key":"10.1016\/bs.acc.2017.06.005_bb0375","unstructured":"CA2 (Calcium Gen.2), Cobas system [package insert], Indianapolis, IN, Roche Diagnostics, 2012."},{"key":"10.1016\/bs.acc.2017.06.005_bb0380","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.clinbiochem.2013.12.027","article-title":"Evaluation of NM-BAPTA method for plasma total calcium measurement on Cobas 8000\u00ae","volume":"47","author":"Bourguignon","year":"2014","journal-title":"Clin. Biochem."},{"key":"10.1016\/bs.acc.2017.06.005_bb0385","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.plabm.2015.09.001","article-title":"The pH of chemistry assays plays an important role in monoclonal immunoglobulin interferences","volume":"3","author":"Alberti","year":"2015","journal-title":"Pract. Lab. Med."},{"key":"10.1016\/bs.acc.2017.06.005_bb0390","series-title":"Tietz Textbook of Clinical Chemistry and Molecular Diagnostics","first-page":"1900","article-title":"Mineral and bone metabolism","year":"1999"},{"key":"10.1016\/bs.acc.2017.06.005_bb0395","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/000456328802500501","article-title":"The measurement of ionized calcium in blood plasma","volume":"25","author":"Buchley","year":"1988","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/bs.acc.2017.06.005_bb0400","series-title":"Methods in Clinical Chemistry","first-page":"1010","article-title":"Ionized calcium","author":"Toffaletti","year":"1987"},{"key":"10.1016\/bs.acc.2017.06.005_bb0405","series-title":"Contemporary Practice in Clinical Chemistry","first-page":"520","article-title":"Calcium biology and disorders","author":"Winter","year":"2011"},{"key":"10.1016\/bs.acc.2017.06.005_bb0410","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrendo.2009.196","article-title":"The FGF23\u2013Klotho axis: endocrine regulation of phosphate homeostasis","volume":"5","author":"Razzaque","year":"2009","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/bs.acc.2017.06.005_bb0415","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1096\/fj.10-154765","article-title":"Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule","volume":"24","author":"Hu","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/bs.acc.2017.06.005_bb0420","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/ki.2014.316","article-title":"Molecular interactions of FGF23 and PTH in phosphate regulation","volume":"86","author":"Lanske","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/bs.acc.2017.06.005_bb0425","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev.med.051308.111339","article-title":"Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23","volume":"61","author":"Bergwitz","year":"2010","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/bs.acc.2017.06.005_bb0430","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1006\/bbrc.2000.3696","article-title":"Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain","volume":"277","author":"Yamashita","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.acc.2017.06.005_bb0435","series-title":"Tietz Textbook of Clinical Chemistry and Molecular Diagnostics","first-page":"1749","article-title":"Bone and mineral metabolism","year":"2012"},{"key":"10.1016\/bs.acc.2017.06.005_bb0440","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/clinchem\/18.3.263","article-title":"Direct method for determining inorganic phosphate in serum with the \u201cCentrifiChem\u201d","volume":"18","author":"Daly","year":"1972","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2017.06.005_bb0445","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1479-5876-11-201","article-title":"The clinical utility of bone marker measurements in osteoporosis","volume":"11","author":"Wheater","year":"2013","journal-title":"J. Transl. Med."},{"key":"10.1016\/bs.acc.2017.06.005_bb0450","series-title":"Primer on the Bone Metabolic Disease and Disorders of Mineral Metabolism","first-page":"198","article-title":"Epidemiology of osteoporotic fractures","author":"Harvey","year":"2008"},{"key":"10.1016\/bs.acc.2017.06.005_bb0455","series-title":"Dynamics of Bone and Cartilage Metabolism","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/B9-78-012088-5\/62650-039X","article-title":"Monitoring anabolic treatment","author":"Bilezikian","year":"2006"},{"key":"10.1016\/bs.acc.2017.06.005_bb0460","series-title":"Primer on the Bone Metabolic Disease and Disorders of Mineral Metabolism","first-page":"174","article-title":"Biochemical markers on bone turnover in osteoporosis","author":"Szulc","year":"2008"},{"key":"10.1016\/bs.acc.2017.06.005_bb0465","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/bs.acc.2017.06.005_bb0470","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1210\/jcem-67-5-876","article-title":"Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure","volume":"67","author":"Pitts","year":"1988","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2017.06.005_bb0475","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/bs.acc.2017.06.005_bb0480","series-title":"UpToDate","article-title":"Overview of chronic kidney disease-mineral bone disease (CKD-MBD)","author":"Qunibi","year":"2015"},{"key":"10.1016\/bs.acc.2017.06.005_bb0485","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJM197712082972307","article-title":"Rickets due to calcium deficiency","volume":"297","author":"Kooh","year":"1977","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.acc.2017.06.005_bb0490","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1542\/peds.46.6.865","article-title":"Calcium deficiency rickets and the renal response to calcium infusion","volume":"46","author":"Maltz","year":"1970","journal-title":"Pediatrics"},{"key":"10.1016\/bs.acc.2017.06.005_bb0495","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/BF00443112","article-title":"Rickets due to dietary calcium deficiency","volume":"148","author":"Legius","year":"1989","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/bs.acc.2017.06.005_bb0500","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0022-3476(78)80035-3","article-title":"Rickets in children of rural origin in South Africa: is low dietary calcium a factor?","volume":"92","author":"Pettifor","year":"1978","journal-title":"J. Pediatr."},{"key":"10.1016\/bs.acc.2017.06.005_bb0505","first-page":"69","article-title":"Dietary calcium intake in rural black South African children: the relationship between calcium intake and calcium nutritional status","volume":"40C","author":"Eyberg","year":"1986","journal-title":"Hum. Nutr. Clin. Nutr."},{"key":"10.1016\/bs.acc.2017.06.005_bb0510","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0221-8747(81)90013-8","article-title":"Dietary calcium deficiency: a syndrome associated with bone deformities and elevated serum 1,25-dihydroxyvitamin D concentrations","volume":"2","author":"Pettifor","year":"1981","journal-title":"Metab. Bone Relat. Res."},{"key":"10.1016\/bs.acc.2017.06.005_bb0515","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM198209023071003","article-title":"Histological osteomalacia due to dietary calcium deficiency in children","volume":"307","author":"Marie","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.acc.2017.06.005_bb0520","series-title":"Tietz Textbook of Clinical Chemistry and Molecular Diagnostics","first-page":"1782","article-title":"Bone and mineral metabolism","author":"Winter","year":"2012"},{"key":"10.1016\/bs.acc.2017.06.005_bb0525","series-title":"UpToDate","article-title":"Clinical manifestations and diagnosis of Paget disease of bone","author":"Seton","year":"2016"},{"key":"10.1016\/bs.acc.2017.06.005_bb0530","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1007\/s00198-016-3561-3","article-title":"The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club","volume":"27","author":"Cavalier","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/bs.acc.2017.06.005_bb0535","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.acc.2017.06.005_bb0540","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1620\/tjem.224.105","article-title":"Suitability of tartrate-resistant acid phosphatase type 5b as a screening marker for bone mineral density in community-dwelling elderly individuals","volume":"224","author":"Irie","year":"2011","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/bs.acc.2017.06.005_bb0545","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1359\/jbmr.2000.15.7.1337","article-title":"Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption","volume":"15","author":"Halleen","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/bs.acc.2017.06.005_bb0550","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2011-3419","article-title":"Serum sclerostin and risk of hip fracture in older Caucasian women","volume":"97","author":"Arasu","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2017.06.005_bb0555","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/jcp.2010.086595","article-title":"Osteoprotegerin, RANKL and bone turnover in postmenopausal osteoporosis","volume":"64","author":"Jabbar","year":"2011","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/bs.acc.2017.06.005_bb0560","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mce.2015.10.015","article-title":"Circulating microRNAs as novel biomarkers for bone diseases\u2014complex signatures for multifactorial diseases?","volume":"432","author":"Hackl","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/bs.acc.2017.06.005_bb0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/BJMMR\/2016\/24738","article-title":"Evaluation of osteopontin in combination with bone turnover markers for the assessment of osteoporosis in postmenopausal women","volume":"14","author":"Reza","year":"2016","journal-title":"Br. J. Med. Med. Res."},{"key":"10.1016\/bs.acc.2017.06.005_bb0570","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/003655101753218274","article-title":"Serum bone sialoprotein: a marker of bone resorption in postmenopausal osteoporosis","volume":"61","author":"Shaarawy","year":"2001","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/bs.acc.2017.06.005_bb0575","series-title":"UpToDate","article-title":"Use of biochemical markers of bone turnover in osteoporosis","author":"Rosen","year":"2016"},{"key":"10.1016\/bs.acc.2017.06.005_bb0580","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/0004563213515190","article-title":"Biochemical markers of bone turnover\u2014uses and limitations","volume":"51","author":"Hlaing","year":"2014","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/bs.acc.2017.06.005_bb0585","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1590\/0001-3765201520150008","article-title":"Bone turnover markers for early detection of fracture healing disturbances: a review of the scientific literature","volume":"87","author":"Sousa","year":"2015","journal-title":"An. Acad. Bras. Cienc."},{"key":"10.1016\/bs.acc.2017.06.005_bb0590","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2106\/JBJS.I.00919","article-title":"The assessment of fracture risk","volume":"92","author":"Unnanuntana","year":"2010","journal-title":"J. Bone Joint Surg. Am."},{"issue":"10","key":"10.1016\/bs.acc.2017.06.005_bb0595","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician's guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporos. Int."},{"key":"10.1016\/bs.acc.2017.06.005_bb0600","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00774-004-0547-6","article-title":"Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004)","volume":"23","author":"Nishizawa","year":"2005","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/bs.acc.2017.06.005_bb0605","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s00223-014-9842-y","article-title":"A meta-analysis of reference markers of bone turnover for prediction of fracture","volume":"94","author":"Johansson","year":"2014","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/bs.acc.2017.06.005_bb0610","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1359\/jbmr.2003.18.6.1051","article-title":"Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate","volume":"18","author":"Eastell","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/bs.acc.2017.06.005_bb0615","first-page":"2363","article-title":"Monitoring of alendronate treatment and prediction of effect on bone mass by biochemical markers in the early postmenopausal intervention cohort study","volume":"84","author":"Ravn","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2017.06.005_bb0620","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s002239900541","article-title":"Utility of biochemical markers of bone turnover in the follow-up of patients treated with bisphosphonates","volume":"63","author":"Rosen","year":"1998","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/bs.acc.2017.06.005_bb0625","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1093\/clinchem\/44.11.2290","article-title":"Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides","volume":"44","author":"Christgau","year":"1998","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2017.06.005_bb0630","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1359\/JBMR.040512","article-title":"Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial","volume":"19","author":"Bauer","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/bs.acc.2017.06.005_bb0635","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/PL00005830","article-title":"Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy","volume":"66","author":"Rosen","year":"2000","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/bs.acc.2017.06.005_bb0640","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","article-title":"Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards","volume":"22","author":"Vasikaran","year":"2011","journal-title":"Osteoporos. Int."},{"key":"10.1016\/bs.acc.2017.06.005_bb0645","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s12020-016-0900-2","article-title":"The use of biochemical markers of bone turnover in the clinical management of primary and secondary osteoporosis","volume":"52","author":"Vasikaran","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/bs.acc.2017.06.005_bb0650","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1007\/s00198-012-2049-z","article-title":"National Bone Health Alliance Bone Turnover Marker Project: current practices and the need for US harmonization, standardization, and common reference ranges","volume":"23","author":"Bauer","year":"2012","journal-title":"Osteoporos. Int."},{"key":"10.1016\/bs.acc.2017.06.005_bb0655","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S8756-3282(02)00791-3","article-title":"Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting","volume":"31","author":"Qvist","year":"2002","journal-title":"Bone"},{"key":"10.1016\/bs.acc.2017.06.005_bb0660","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1530\/eje.0.1400332","article-title":"Acute fasting diminishes the circadian rhythm of biochemical markers of bone resorption","volume":"140","author":"Schlemmer","year":"1999","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/bs.acc.2017.06.005_bb0665","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1373\/clinchem.2004.039958","article-title":"Procollagen type I amino-terminal propeptide: pediatric reference data and relationship with procollagen type I carboxyl-terminal propeptide","volume":"50","author":"Crofton","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2017.06.005_bb0670","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.bone.2009.07.091","article-title":"Rapid and robust response of biochemical markers of bone formation to teriparatide therapy","volume":"45","author":"Glover","year":"2009","journal-title":"Bone"},{"key":"10.1016\/bs.acc.2017.06.005_bb0675","first-page":"80","article-title":"Biochemical markers in the follow-up of the osteoporotic patients","volume":"9","author":"Terreni","year":"2012","journal-title":"Clin. Cases Miner. Bone Metab."},{"key":"10.1016\/bs.acc.2017.06.005_bb0680","author":"Orion Diagnostica"},{"key":"10.1016\/bs.acc.2017.06.005_bb0685","unstructured":"Immunodiagnosticsystems, Fully automated intact PINP. http:\/\/www.pantec.it\/files\/IDS-iSYS-Intact-PINP-IS-4000.pdf. Accessed 8 June 2016."},{"key":"10.1016\/bs.acc.2017.06.005_bb0690","unstructured":"Roche Diagnostics. http:\/\/www.roche.com\/products\/product-list.htm?region=us&type=diagnostics&id=24. Accessed June 8, 2016."},{"key":"10.1016\/bs.acc.2017.06.005_bb0695","unstructured":"USCN Life Science. ELISA kit. http:\/\/www.uscnk.us\/elisa\/ELISA-Kit-for-Human-Procollagen-I-N-Terminal-Propeptide-PINP-1354.htm. Accessed June 8 2016."},{"key":"10.1016\/bs.acc.2017.06.005_bb0700","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.clinbiochem.2012.03.023","article-title":"Measurement of aminoterminal propeptide of type 1 procollagen (P1NP) in serum","volume":"45","author":"Koivula","year":"2012","journal-title":"Clin. Biochem."},{"key":"10.1016\/bs.acc.2017.06.005_bb0705","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s00198-014-2646-0","article-title":"PINP as a biological response marker during teriparatide treatment for osteoporosis","volume":"25","author":"Krege","year":"2014","journal-title":"Osteoporos. Int."},{"key":"10.1016\/bs.acc.2017.06.005_bb0710","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/clinchem\/42.3.480","article-title":"Standards required for quantification of skeletal alkaline phosphatase","volume":"42","author":"Klein","year":"1996","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2017.06.005_bb0715","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1093\/clinchem\/44.10.2139","article-title":"Analytical and clinical performance characteristics of Tandem-MP Ostase, a new immunoassay for serum bone alkaline phosphatase","volume":"44","author":"Broyles","year":"1998","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2017.06.005_bb0720","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1093\/clinchem\/43.11.2052","article-title":"Direct comparison of performance characteristics of two immunoassays for bone isoform of alkaline phosphatase in serum","volume":"43","author":"Price","year":"1997","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2017.06.005_bb0725","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1210\/jc.2009-0835","article-title":"Bone mineral density and serum levels of soluble tumor necrosis factors, estradiol, and osteoprotegerin in postmenopausal women with cirrhosis after viral hepatitis","volume":"94","author":"Gonz\u00e1lez-Calvin","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2017.06.005_bb0730","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mce.2009.04.004","article-title":"A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms","volume":"310","author":"Confavreux","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/bs.acc.2017.06.005_bb0735","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.tem.2009.02.001","article-title":"Bone as an endocrine organ","volume":"20","author":"Fukumoto","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2017.06.005_bb0740","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/jbmr.5650071119","article-title":"A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine","volume":"7","author":"Hanson","year":"1992","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/bs.acc.2017.06.005_bb0745","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/clinchem\/41.8.1195","article-title":"Effect of light and gamma-irradiation on pyridinolines and telopeptides of type I collagen in urine","volume":"41","author":"Blumsohn","year":"1995","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2017.06.005_bb0750","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/clinchem\/43.11.2058","article-title":"Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption","volume":"43","author":"Clemens","year":"1997","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2017.06.005_bb0755","first-page":"864","article-title":"Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): follow-up on hormone replacement therapy and osteoporosis risk assessment","volume":"80","author":"Bonde","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2017.06.005_bb0760","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S8756-3282(96)00229-3","article-title":"The effect on bone mass and bone markers of different doses of ibandronate: a new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: a 1-year, randomized, double-blind, placebo-controlled dose-finding study","volume":"19","author":"Ravn","year":"1996","journal-title":"Bone"},{"key":"10.1016\/bs.acc.2017.06.005_bb0765","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/clinchem\/44.11.2281","article-title":"Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen","volume":"44","author":"Rosenquist","year":"1998","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2017.06.005_bb0770","series-title":"\u03b2-CrossLaps\/serum (\u03b2-CTx in serum), Cobas system [package insert]","year":"2015"},{"key":"10.1016\/bs.acc.2017.06.005_bb0775","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1101\/gad.1854909","article-title":"Breaking down bone: new insight into site-specific mechanisms of breast cancer osteolysis mediated by metalloproteinases","volume":"23","author":"Guise","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/bs.acc.2017.06.005_bb0780","doi-asserted-by":"crossref","unstructured":"T. A. Guise, K. S. Mohammad, G. Clines, E. G. Stebbins, D. H. Wong, L. S. Higgins, R. Vessella, E. Corey, S. Padalecki, L. Suva, J. M. Chirgwin, Basic mechanisms responsible for osteolytic and osteoblastic bone metastases, Clin. Cancer Res. 12 (2006), pp. 6213s\u20136216s.","DOI":"10.1158\/1078-0432.CCR-06-1007"},{"key":"10.1016\/bs.acc.2017.06.005_bb0785","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1196\/annals.1346.035","article-title":"Bone destruction in multiple myeloma","volume":"1068","author":"Matsumoto","year":"2006","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/bs.acc.2017.06.005_bb0790","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bone.2010.06.016","article-title":"Osteoblastic function in myeloma","volume":"48","author":"Roodman","year":"2011","journal-title":"Bone"},{"key":"10.1016\/bs.acc.2017.06.005_bb0795","first-page":"671","article-title":"Procollagen type 1 amino-terminal propeptide: a marker for bone metastases in prostate carcinoma","volume":"29","author":"Klepzig","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/bs.acc.2017.06.005_bb0800","first-page":"2443","article-title":"Value of procollagen type 1 amino-terminal propeptide in patients with renal cell carcinoma","volume":"28","author":"Klepzig","year":"2008","journal-title":"Anticancer Res."},{"key":"10.1016\/bs.acc.2017.06.005_bb0805","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.juro.2007.05.029","article-title":"Serum bone turnover markers (PINP and ICTP) for the early detection of bone metastases in patients with prostate cancer: a longitudinal approach","volume":"178","author":"Koopmans","year":"2007","journal-title":"J. Urol."}],"container-title":["Advances in Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242317300471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242317300471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T19:34:59Z","timestamp":1758742499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065242317300471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9780128120736"],"references-count":160,"URL":"https:\/\/doi.org\/10.1016\/bs.acc.2017.06.005","relation":{},"ISSN":["0065-2423"],"issn-type":[{"value":"0065-2423","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}